ATOSSA THERAPEUTICS, INC. Quarterly Common Stock, Shares Authorized from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Atossa Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2011 to Q2 2024.
  • Atossa Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2024 was 350M shares, a 100% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 350M +175M +100% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 175M 0 0% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 175M 0 0% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 175M 0 0% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 175M 0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 175M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 175M 0 0% Dec 31, 2022 10-K 2024-04-01
Q3 2022 175M 0 0% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 175M 0 0% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 175M 0 0% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 175M 0 0% Dec 31, 2021 10-K 2023-03-22
Q3 2021 175M 0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 175M 0 0% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 175M 0 0% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 175M 0 0% Dec 31, 2020 10-K 2022-02-28
Q3 2020 175M 0 0% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 175M 0 0% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 175M 0 0% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 175M 0 0% Dec 31, 2019 10-K 2021-03-31
Q3 2019 175M 0 0% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 175M 0 0% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 175M +100M +133% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 175M 0 0% Dec 31, 2018 10-K 2020-03-26
Q3 2018 175M +100M +133% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 175M +100M +133% Jun 30, 2018 10-Q/A 2018-11-13
Q1 2018 75M 0 0% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 175M +100M +133% Dec 31, 2017 10-K 2019-03-28
Q3 2017 75M 0 0% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 75M 0 0% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 75M 0 0% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 75M 0 0% Dec 31, 2016 10-K 2018-03-08
Q3 2016 75M 0 0% Sep 30, 2016 10-Q/A 2017-03-21
Q2 2016 75M 0 0% Jun 30, 2016 10-Q/A 2017-03-21
Q1 2016 75M 0 0% Mar 31, 2016 10-Q/A 2017-03-21
Q4 2015 75M 0 0% Dec 31, 2015 10-Q/A 2017-03-21
Q3 2015 75M 0 0% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 75M 0 0% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 75M 0 0% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 75M 0 0% Dec 31, 2014 10-K 2016-03-30
Q3 2014 75M 0 0% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 75M 0 0% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 75M 0 0% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 75M 0 0% Dec 31, 2013 10-K 2015-03-30
Q3 2013 75M 0 0% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 75M Jun 30, 2013 10-Q 2013-08-14
Q1 2013 75M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 75M 0 0% Dec 31, 2012 10-K 2014-03-27
Q3 2012 75M Sep 30, 2012 10-Q/A 2013-01-22
Q4 2011 75M Dec 31, 2011 10-K 2013-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.